Literature DB >> 8021764

Shigellosis in neonates and young infants.

W C Huskins1, J K Griffiths, A S Faruque, M L Bennish.   

Abstract

To determine the clinical features and outcome of shigellosis in young infants, we reviewed the hospital records of 159 infants < or = 3 months of age (including 30 neonates) and 159 children 1 to 10 years of age with shigellosis who were admitted to the Diarrhoea Treatment Centre in Dacca, Bangladesh. Infants more commonly had a history of nonbloody diarrhea (82.8% vs 42.7%; p < 0.001), moderate or severe dehydration (59.9% vs 32.1%; p < 0.001), or bacteremia (12.0% vs 5.0%; p = 0.027) and less commonly had fever (32.7% vs 58.6%; p < 0.001), abdominal tenderness (1.9% vs 12.6%; p < 0.001), or rectal prolapse (0% vs 8.3%; p = 0.001). Infections caused by Shigella boydii (20.8% vs 6.3%; p < 0.001) and Shigella sonnei (7.5% vs 1.3%; p = 0.006) were more common, and Shigella dysenteriae type 1 (9.4% vs 31.4%; p < 0.001) infections were less common in infants than in older children; the proportion of Shigella flexneri infections was equivalent in the two groups (59.1% vs 60.4%). Infants were twice as likely to die as older children (16.4% vs 8.2%; p = 0.026). Only 17 infants (14.3%) were being exclusively breast fed at the onset of their illness. In a multiple logistic regression analysis, independent predictors of death in infants were gram-negative bacteremia, ileus, decreased bowel sounds, hyponatremia, hypoproteinemia, and a lower number of erythrocytes detected on microscopic examination of stool specimens. Diarrhea management algorithms that rely only on clinical findings of dysentery to diagnose and treat shigellosis are likely to be unreliable in this high-risk age group.

Entities:  

Keywords:  Age Factors; Asia; Bacterial And Fungal Diseases; Bangladesh; Child; Demographic Factors; Developing Countries; Diseases; Infant; Infections; Population; Population Characteristics; Research Report; Signs And Symptoms; Southern Asia; Youth

Mesh:

Year:  1994        PMID: 8021764     DOI: 10.1016/s0022-3476(94)70115-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

Authors:  P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-12       Impact factor: 3.164

2.  Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth.

Authors:  Yiping W Han; Tao Shen; Peter Chung; Irina A Buhimschi; Catalin S Buhimschi
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

3.  Shigellosis and Pregnancy in French Guiana: Obstetric and Neonatal Complications.

Authors:  Michaël Parisot; Anne Jolivet; Rachida Boukhari; Gabriel Carles
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

Review 4.  Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis.

Authors:  Kirkby D Tickell; Rebecca L Brander; Hannah E Atlas; Jeffrey M Pernica; Judd L Walson; Patricia B Pavlinac
Journal:  Lancet Glob Health       Date:  2017-12       Impact factor: 38.927

Review 5.  Vomiting, diarrhea, constipation, and gastroenteritis.

Authors:  Leila Getto; Eli Zeserson; Michael Breyer
Journal:  Emerg Med Clin North Am       Date:  2011-05       Impact factor: 2.264

6.  Diarrhea in an infant due to Shigella flexneri 1 carrying multiple cephalosporinase-encoding genes.

Authors:  M John Albert; Prashant Purohit; Laurent Poirel; Glen Carter; Dieter Bulach
Journal:  Gut Pathog       Date:  2021-03-20       Impact factor: 4.181

7.  Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.

Authors:  Patricia B Pavlinac; Elizabeth T Rogawski McQuade; James A Platts-Mills; Karen L Kotloff; Carolyn Deal; Birgitte K Giersing; Richard A Isbrucker; Gagandeep Kang; Lyou-Fu Ma; Calman A MacLennan; Peter Patriarca; Duncan Steele; Kirsten S Vannice
Journal:  Vaccines (Basel)       Date:  2022-03-22

8.  Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic.

Authors:  Wasif A Khan; Jeffrey K Griffiths; Michael L Bennish
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

9.  The Clinical Presentation of Culture-positive and Culture-negative, Quantitative Polymerase Chain Reaction (qPCR)-Attributable Shigellosis in the Global Enteric Multicenter Study and Derivation of a Shigella Severity Score: Implications for Pediatric Shigella Vaccine Trials.

Authors:  Patricia B Pavlinac; James A Platts-Mills; Kirkby D Tickell; Jie Liu; Jane Juma; Furqan Kabir; Joseph Nkeze; Catherine Okoi; Darwin J Operario; Jashim Uddin; Shahnawaz Ahmed; Pedro L Alonso; Martin Antonio; Stephen M Becker; Robert F Breiman; Abu S G Faruque; Barry Fields; Jean Gratz; Rashidul Haque; Anowar Hossain; M Jahangir Hossain; Sheikh Jarju; Farah Qamar; Najeeha Talat Iqbal; Brenda Kwambana; Inacio Mandomando; Timothy L McMurry; Caroline Ochieng; John B Ochieng; Melvin Ochieng; Clayton Onyango; Sandra Panchalingam; Adil Kalam; Fatima Aziz; Shahida Qureshi; Thandavarayan Ramamurthy; James H Roberts; Debasish Saha; Samba O Sow; Suzanne E Stroup; Dipika Sur; Boubou Tamboura; Mami Taniuchi; Sharon M Tennant; Anna Roose; Deanna Toema; Yukun Wu; Anita Zaidi; James P Nataro; Myron M Levine; Eric R Houpt; Karen L Kotloff
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

10.  Associated factors, post infection child growth, and household cost of invasive enteritis among under 5 children in Bangladesh.

Authors:  Rina Das; Md Ahshanul Haque; Mohammod Jobayer Chisti; A S G Faruque; Tahmeed Ahmed
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.